BESCHICHTETES PRÄPARAT

European patent · EP2172200 · In force

Register entry

Publication number
EP2172200
Application number
EP08791071
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 10, 2008
Published
Apr 7, 2010
Granted
Sep 16, 2015
Protection ends at the latest
Jul 9, 2028
Next annual fee due
Jul 31, 2027
IPC classes
A61K 31/4439 (2006.01)
A61K 9/16 (2006.01)
A61K 9/20 (2006.01)
A61K 9/48 (2006.01)
A61K 9/50 (2006.01)
Priority
JP 2007183749 12.07.2007
PCT application
PCT/JP2008/062523 10.07.2008
PCT publication
WO2009/008487 15.01.2009
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Dec 9, 2015

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 09.12.2015

  7. Sep 16, 2015

    Granted

    Published in Swissreg on 16.09.2015

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

BANDO, Hiroto

Osaka-shi Osaka 540-8645, JP

OMACHI, Yoshihiro

Osaka-shi Osaka 532-8686, JP

KIYOSHIMA, Kenichiro

Osaka-shi Osaka 532-8686, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.